Each week, Crowell & Moring’s State Attorneys General team highlights significant actions that State AGs have taken. See our State Attorneys General page for more insights. Below are the updates from August 20-27, 2026:

Multistate

• A coalition of 48 states and territories, announced by Idaho Attorney General Labrador and others, reached a $29.6 million settlement with generic drug manufacturer Glenmark to resolve allegations that the company participated in a long-running conspiracy to artificially inflate prices, suppress competition, and unreasonably restrain trade in numerous generic prescription drugs, in violation of federal antitrust laws. The Glenmark settlement follows earlier settlements with Lannett, Bausch, Apotex, and Heritage totaling $66.95 million, and comes as the states prepare for a first trial anticipated to be scheduled in late 2026 in Hartford, Connecticut. As part of the agreement, Glenmark will cooperate in the ongoing multistate litigations against 33 corporate defendants and 25 individual executives and will implement a series of internal compliance reforms. Idaho is one of only two states in the coalition that also secured restitution for businesses—not only consumers—that were indirectly affected by the price-fixing scheme.